Increased apoptosis in HepG2.2.15 cells with hepatitis B virus expression by synergistic induction of interferon-γ and tumour necrosis factor-α

Liver International

Volumn 29, Issue 3, 2009, Pages 349-355

  Shi, Hong ^a   Guan, Shi He ^b  

^a FUDAN UNIVERSITY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Hepatitis B virus; Interferon ; Tumour necrosis factor

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CASPASE 7; COMPLEMENTARY DNA; DNA; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; INTERFERON REGULATORY FACTOR 1; LAMIVUDINE; MYC PROTEIN; RECOMBINANT GAMMA INTERFERON; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

AGAR GEL ELECTROPHORESIS; ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; CELL STRAIN HEPG2; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; MICROSCOPY; MONOTHERAPY; NUCLEOTIDE SEQUENCE; PROTEIN INDUCTION; UNINDEXED SEQUENCE; UPREGULATION;

APOPTOSIS; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; INTERFERON-GAMMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TETRAZOLIUM SALTS; THIAZOLES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 59849111088     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2008.01835.x     Document Type: Article

References (32)

1. Akbar F, Yoshida O, Abe M, Hiasa Y, Onji M. Engineering immune therapy against hepatitis B virus. Hepatol Res 2007; 37: 351-6.
2. Hoofnagle JH, Doo E, Liang TJ, Fleischer R, Lok AS. Management of hepatitis B: Summary of a clinical research workshop. Hepatology 2007; 45: 1056-75.
3. Herzer K, Sprinzl MF, Galle PR. Hepatitis viruses: Live and let die. Liver Int 2007; 27: 293-301.
4. Guidotti LG, Chisari FV. To kill or to cure: Options in host defense against viral infection. Curr Opin Immunol 1996; 8: 478-83.
5. Ganem D, Prince AM. Hepatitis B virus infection - natural history and clinical consequences. N Eng J Med 2004; 350: 1118-29.
6. Reifenberg K, Hildt E, Lecher B, et al. IFN-γ expression inhibits LHBs storage disease and ground glass hepatocyte appearance, but exacerbates inflammation and apoptosis in HBV surface protein-accumulating transgenic livers. Liver Int 2006; 26: 986-93.
7. Su F, Schneider RJ. Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor α. Proc Natl Acad Sci USA 1997; 94: 8744-9.
8. Tang YM, Chen MH, Chen GH, et al. Kinetics of phytohemaglutinin-induced IFN-γ and TNF-α expression in peripheral blood mononuclear cells from patients with chronic hepatitis B after liver transplantation. World J Gastroenterol 2005; 11: 4574-8.
9. Pasquetto V, Wieland SF, Uprichard SL, Tripodi M, Chisari FV. Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures. J Virol 2002; 76: 5646-53.
10. Schlaak JF, Hilkens CM, Costa- Pereira AP, et al. Cell-type and donor-specific transcriptional responses to interferon-alpha. Use of customized gene arrays. J Biol Chem 2002; 277: 49428-37.
11. Guan SH, Lu M, Gruenewald P, Roggendorf M, Gerken G, Schlaak JF. Interferon-α response in chronic hepatitis B- transfected HepG2.2.15 cells is partially restored by lamivudine treatment. World J Gastroenterol 2007; 13: 228-35.
12. Neuman MG. Apoptosis in diseases of the liver. Crit Rev Clin Lab Sci 2001; 38: 109-66.
13. Dealtry GB, Naylor MS, Fiers W, Balkwill FR. DNA fragmentation and cytotoxicity caused by tumor necrosis factor is enhanced by interferon-gamma. Eur J Immunol 1987; 17: 689-93.
14. Fish SM, Proujansky R, Reenstra WW. Synergistic effects of interferon γ and tumor necrosis factor α on T84 cell function. Gut 1999; 45: 191-8.
15. Suk K, Kim S, Kim YH, et al. IFN-γ/TNF-α synergism as the final effector in autoimmune diabetes: A key role for STAT1/IFN regulatory factor -1 pathway in pancreatic β cell death. J Immunol 2001; 166: 4481-9.
16. Kamachi M, Kawakami A, Yamasaki S, et al. Regulation of apoptotic cell death by cytokines in a human salivary gland cell line: Distinct and synergistic mechanisms in apoptosis induced by tumor necrosis factor α and interferon γ. J Lab Clin Med 2002; 139: 13-9.
17. Buntinx M, Moreels M, Vandenabeele F, et al. Cytokine-induced cell death in human oligodendroglial cell lines: Synergistic effects of IFN-γ and TNF-α on apoptosis. J Neurosci Res 2004; 76: 834-45.
18. Sasagawa T, Hlaing M, Akaike T. Synergistic induction of apoptosis in murine hepatoma Hepa 1-6 cells by IFN-γ and TNF-α. Biochem Biophys Res Commun 2000; 272: 674-80.
19. Powis SH, Mockridge I, Kelly A, et al. Polymorphism in a second ABC transporter gene located within the class II region of the human major histocompatibility complex. Proc Natl Acad Sci USA 1992; 89: 1463-7.
20. Pai M, Prabhu R, Panebra A, et al. Activation of interferon- stimulated response element in huh-7 cells replicating hepatitis C virus subgenomic RNA. Intervirology 2005; 48: 301-1.
21. Anderson SL, Carton JM, Lou J, Xing L, Rubin BY. Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus. Virology 1999; 256: 8-14.
22. Coupel S, Moreau A, Hamidou M, Horejsi V, Soulillou JP, Charreau B. Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation. Blood 2007; 109: 2806-14.
23. Chen Y, Cheng M, Tian Z. Hepatitis B virus down-regulates expressions of MHC class I molecules on hepatoplastoma cell line. Cell Mol Immunol 2006; 3: 373-8.
24. Volpes R, van den Oord JJ, De Vos R, Depla E, De Ley M, Desmet VJ. Expression of interferon-gamma receptor in normal and pathological human liver tissue. J Hepatol 1991; 12: 195-202.
25. Tanaka N, Ishihara M, Kitagawa M, et al. Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell 1994; 77: 829-39.
26. Mori K, Stone S, Khaodhiar L, Braverman LE, DeVito WJ. Induction of transcription factor interferon regulatory factor- 1 by interferon-γ and tumor necrosis factor-α in FRTL-5 cells. J Cell Biochem 1999; 74: 211-9.
27. Suk K, Chang I, Kim YH, et al. Interferon γ and tumor necrosis factor α synergism in ME-180 cervical cancer cell apoptosis and necrosis. IFNγ inhibits cytoprotective NF-KappaB through STAT1/ IRF-1 pathways. J Biol Chem 2001; 276: 13153-9.
28. Kroeger A, Koester M, Schroeder K, Hauser H, Mueller PP. Activities of IRF-1. J Interferon Cytokine Res 2002; 22: 5-14.
29. Taniguchi T, Ogasawara K, Takaoka A, Tanaka N. IRF family of transcription factors as regulators of host defense. Annu Rev Immunol 2001; 19: 623-55.
30. Kim PK, Armstrong M, Liu Y, et al. IRF-1 expression induces apoptosis and inhibits tumor growth in mouse mammary cancer cells in vitro and in vivo. Oncogene 2004; 23: 1125-35.
31. You Z, Madrid LV, Saims D, Sedivy J, Wang CY. c-Myc sensitizes cells to tumor necrosis factor-mediated apoptosis by inhibiting nuclear factor k B transactivation. J Biol Chem 2002; 277: 36671-7.
32. Mastumura I, Tanaka H, Kanakura Y. E2F1 and c-Myc in cell growth and death. Cell Cycle 2003; 2: 333-8.